Trinity Biotech Plc ADR (TRIB)’s stock is trading at $1.1 at the moment marking a rise of 3.30% from the last session close. As of this writing, shares are priced at -68.17% less than their 52-week high of $3.44, and 128.13% over their 52-week low of $0.48. Based on the past 30-day period, the stock price is -13.14% below the high and +10.90% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, TRIB’s SMA-200 is $0.8477.
How does Trinity Biotech Plc ADR (TRIB) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.
Trinity Biotech Plc ADR (TRIB): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -1.85 and -1.85 with an average Earnings Estimate of -1.85 which is in contrast with the last year earnings estimate of -2.15 and also replicates 13.95% growth rate year over year.
Trinity Biotech Plc ADR (NASDAQ: TRIB) Ownership Details
I will give a breakdown of the key shareholders in Trinity Biotech Plc ADR (TRIB). Recent figures show that the company’s insiders hold 12.01% of shares. A total of 25 institutional investors hold shares in the company, making 14.13% of its stock and 16.06% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holding total of 16.64 shares that make 0.74% of the company’s total number of shares and are currently priced at 18222.0.
An overview of Trinity Biotech Plc ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Trinity Biotech Plc ADR (TRIB) traded 128,330 shares per day, with a moving average of $1.1240 and price change of -0.0910. With the moving average of $1.1932 and a price change of +0.4290, about 5,531,692 shares changed hands on average over the past 50 days. Finally, TRIB’s 100-day average volume is 3,287,368 shares, alongside a moving average of $0.9414 and a price change of +0.2618.
